Tus kws kho mob
QP48-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Somatostatin Analogs
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2231 - 2240 ntawm 4303
Tus kws kho mob
QP47-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary transthyretin-mediated (hATTR) Amyloidosis Neuropathy
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019
Tus kws kho mob
QP57-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization Criteria: tafamidis
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019
Tus kws kho mob
QP49-19 Pharmacy Benefit Exclusion for Proventil (albuterol sulfate) HFA and Proventil (albuterol sulfate) HFA Authorized Generic (AG)
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019
Tus kws kho mob
QP54-19 Pharmacy Benefit Update – New Drug-Related Utilization Management Program: Opioid Immediate Release (IR) New to Therapy (NTT) Program
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019
Tus kws kho mob
QP52-19 Pharmacy Benefit Exclusion for Cimzia, Elzonris, Gamifant, Kalbitor, Khapzory, leucovorin calcium, Nuzyra and Panzyga
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019
Tus kws kho mob
QP53-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Neurotrophic Keratitis
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019
Tus kws kho mob
QP59-19 eviCore Group Number List to be Removed
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019
Tus kws kho mob
QP51-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Firdapse
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019
Tus kws kho mob
QP45-19 Providers Need to Validate Members Coverage
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019